Strong Buy CAPR by Sep 1, 2025.

**Ticker**: CAPR (Capricor Therapeutics) **Current Price (Mar 2025):** \~$14 **Market Cap:** \~$580M **My Position:** 835 Sept $15 Calls @ $5.50 (**Yes, I YOLO’d \~$459K**) **Sector:** Biotech / Rare Disease **Catalyst:** FDA **Priority Review** for first-in-class **DMD therapy** – **PDUFA date Aug 31, 2025** **TL;DR:** 🚀 **FDA decision coming in August for a rare disease therapy** with **no direct competition.** Company **fully funded till 2027** (so **no rug-pull dilution** incoming), has a **big pharma partner handling commercialization,** and analysts are **way …